Complete response of mantle cell lymphoma with central nervous system involvement at diagnosis with acalabrutinib - Case report

被引：1

作者：

Barrett, Aisling ^{[1
]}

Eyre, Toby A. ^{[1
]}

Bhuva, Shaheel ^{[2
]}

Aljurf, Mahmoud ^{[3
]}

El Fakih, Riad ^{[3
]}

Ashshi, Mohammad A. ^{[4
]}

Alshaibani, Alfadel ^{[3
,5
]}

机构：

[1] Oxford Univ Hosp NHS Fdn Trust, Oxford Canc & Haematol Ctr, Dept Clin Haematol, Oxford, England

[2] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Radiol, Oxford, England

[3] King Faisal Specialist Hosp & Res Ctr, Dept Stem Cell Transplant & Cellular Therapy, Riyadh, Saudi Arabia

[4] Umm Al Qura Univ, Coll Med, Mecca, Saudi Arabia

[5] King Faisal Specialist Hosp & Res Ctr, Dept Haematol, Riyadh, Saudi Arabia

来源：

EJHAEM | 2024年 / 5卷 / 01期

关键词：

acalabrutinib; case report; central nervous system lymphoma; mantle cell lymphoma; PET in lymphoma;

D O I：

10.1002/jha2.830

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Central nervous system (CNS) involvement by mantle cell lymphoma (MCL) is rare and portends a poor prognosis. We describe the first patient to have a complete response with front-line treatment with single-agent acalabrutinib for MCL CNS. image

引用

页码：238 / 241

页数：4

共 50 条

[41] CiclosporinPrimary central nervous system lymphoma: case report
Reactions Weekly, 2020, 1800 (1) : 96 - 96
[42] NatalizumabPrimary central nervous system lymphoma: case report
Reactions Weekly, 2017, 1679 (1) : 133 - 133
[43] AzathioprinePrimary central nervous system lymphoma: case report
Reactions Weekly, 2014, 1524 (1) : 45 - 45
[44] NatalizumabPrimary central nervous system lymphoma: case report
Reactions Weekly, 2009, 1281 (1) : 23 - 23
[45] Risk factors of central nervous system relapse in mantle cell lymphoma
Conconi, Annarita
Franceschetti, Silvia
Lobetti-Bodoni, Chiara
Stathis, Anastasios
Margiotta-Casaluci, Gloria
Ramponi, Antonio
Mazzucchelli, Luca
Bertoni, Francesco
Ghielmini, Michele
Gaidano, Gianluca
Cavalli, Franco
Zucca, Emanuele
LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 1908 - 1914
[46] MercaptopurinePrimary central nervous system lymphoma: case report
Reactions Weekly, 2024, 2035 (1) : 272 - 272
[47] MercaptopurinePrimary central nervous system lymphoma: case report
Reactions Weekly, 2022, 1924 (1) : 280 - 280
[48] A case report of primary central nervous system lymphoma
Zeng, Xu
Lu, Xiaofei
Li, Xinlong
Peng, Lilei
Chen, Ligang
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (07)
[49] A case report of primary central nervous system lymphoma
Scarioni, M.
Basilico, P.
Pietroboni, A. M.
Arighi, A.
Fumagalli, G. G.
Calvi, A.
Galimberti, D.
Scarpini, E.
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 711 - 712
[50] AdalimumabPrimary central nervous system T-cell lymphoma: case report
Reactions Weekly, 2019, 1747 (1) : 14 - 14

← 1 2 3 4 5 →